Gritstone Oncology

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$57
$49
$29
$1,565
Gross Profit
-1,543
-1,693
-1,892
-399
EBITDA
-20,492
-37,347
-27,679
-35,479
EBIT
-22,092
-39,089
-29,600
-37,443
Net Income
-23,396
-40,385
-30,818
-38,434
Net Change In Cash
57
49
29
1,565
Free Cash Flow
-26,843
-33,710
-34,566
-32,180
Cash
52,174
43,642
65,285
29,539
Basic Shares
143,296
118,391
97,585
115,342

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$1,331
$9,269
$46,717
$4,037
Gross Profit
-6,260
-6,422
32,318
-84,606
EBITDA
-126,863
-111,892
-68,698
-98,670
EBIT
-134,454
-127,583
-83,097
-105,314
Net Income
-138,490
-113,127
-74,955
-104,611
Net Change In Cash
1,331
9,269
46,717
4,037
Cost of Revenue
-45,812
-60,471
112,648
Free Cash Flow
-126,220
-121,818
-56,141
-92,617
Cash
65,285
55,498
93,287
170,056
Basic Shares
115,527
90,918
78,885
37,792

Earnings Calls

Quarter EPS
2024-06-30
-$0.16
2024-03-31
-$0.34
2023-12-31
-$0.26
2023-09-30
-$0.33